home / stock / xcur / xcur news


XCUR News and Press, Exicure Inc. From 06/30/22

Stock Information

Company Name: Exicure Inc.
Stock Symbol: XCUR
Market: OTC
Website: exicuretx.com

Menu

XCUR XCUR Quote XCUR Short XCUR News XCUR Articles XCUR Message Board
Get XCUR Alerts

News, Short Squeeze, Breakout and More Instantly...

XCUR - NeuroSense, Rapid Micro top healthcare gainers; Renalytix, Angion lead losers' pack

Gainers: NeuroSense Therapeutics ( NRSN ) +53% . Rapid Micro Biosystems ( RPID ) +36% . Burning Rock Biotech ( BNR ) +15% . Tyra Biosciences ( TYRA ) +7% . Addex Therapeutics ( ADXN ) +5% . Losers: Renalytix ( RNLX ) -40% ...

XCUR - ArcelorMittal, Universal Health Services, RH among premarket losers' pack

Renalytix ( RNLX ) -28% on Q3 earnings release . Angion Biomedica ( ANGN ) -27% after it discontinued phase 2 trial of ANG-3070 in patients with kidney disease . Exicure ( XCUR ) -23% as it implements reverse-stock-split to get back Nasdaq com...

XCUR - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on! We’ve got a reverse stock split, CEO departure...

XCUR - Exicure slides 31% as it implements reverse-stock-split to get back Nasdaq compliance

Exicure ( NASDAQ: XCUR ) announces that following the implementation of a one-for-thirty reverse stock split, the company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective open of Thursday, June 30, 2022. On December 30, 2021, Nasda...

XCUR - Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split

Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementatio...

XCUR - Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders

Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual ...

XCUR - Exicure up 27% pre market following insider buy

Shares of Exicure (NASDAQ:XCUR) have surged 25% in premarket trading following a large purchase by a member of the company's board of directors. An SEC filing shows that on May 19, Bali Muralidhar, managing director of Abingworth, a healthcare venture capital fund, purchased 1472126 shar...

XCUR - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BEST stock leads our pre-market gainers. EVFM shares are our biggest loser for today. Stocks are moving on various bits of news this morning. Source: ventdusud / Shutterstock.com We’re closing in on the...

XCUR - What to Know About Buying Penny Stocks on May 20th 

Buying Penny Stocks on May 20th? Here’s What You Need to Know With penny stocks and blue chips more volatile than ever, there is a lot that investors need to keep track of. Although trading penny stocks can be difficult, with the right strategies on hand, it can be much easie...

XCUR - Exicure GAAP EPS of -$0.07, revenue of $2.57M

Exicure press release (NASDAQ:XCUR): Q1 GAAP EPS of -$0.07. Revenue of $2.57M (+157.0% Y/Y). Cash, cash equivalents and short-term investments were $27.6 million as of March 31, 2022, as compared to $48.3 million as of December 31, 2021 For further details see: Exicure GAAP EPS of -$0.0...

Previous 10 Next 10